Results 221 to 230 of about 17,128 (260)
Some of the next articles are maybe not open access.
Mortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Journal of Gastroenterology and HepatologyAbstractBackground and AimMetabolic dysfunction‐associated steatotic liver disease (MASLD) has become a leading cause of chronic liver disease worldwide. A new entity termed MetALD has also been described and is defined as individuals with MASLD and increased alcohol intake. However, the natural history of MetALD compared with MASLD is unknown.Majd B. Aboona, Pojsakorn Danpanichkul, Vincent L Chen, Pooja Rangan, Donghee Kim, Naim Alkhouri, Michael B. Fallon, Mazen Noureddin, Juan Pablo Arab, Karn Wijarnpreecha +9 moreopenaire +3 more sourcesPredictors of fibrosis, clinical events, and mortality in MASLD: Data from the Global-MASLD study
Hepatology Background and Aims: Advanced histologic fibrosis is a major predictor of mortality in metabolic dysfunction–associated steatotic liver disease (MASLD). We aimed to identify advanced fibrosis clinical determinants across diverse MASLD populations and to assess the prognostic value of noninvasive markers (NITs ...Zobair M Younossi, Leyla de Avila, Salvatore Petta, Hannes Hagström, Seung Up Kim, Atsushi Nakajima, Javier Crespo, Laurent Castera, Naim Alkhouri, Ming-Hua Zheng, Sombat Treeprasertsuk, Prooksa Ananchuensook, Shalimar, Emmanuel Tsochatzis, Shenoy Kotacherry Trivikrama, Leena Kondarappassery Balakumaran, Jian-Gao Fan, Stuart K Roberts, Khalid Alswat, Vincent Wai-Sun Wong, Yusuf Yilmaz, Winston Dunn, Sven Francque, Ahmed Cordie, Ming-Lung Yu, Mattias Ekstedt, George Boon-Bee Goh, Claudia P Oliveira, Mario Guimaraes Pessoa, Wah Kheong Chan, Marlen Ivon Castellanos Fernandez, Ajay Duseja, Juan Pablo Arab, George Papatheodoridis, Giada Sebastiani, Cristiane Villela-Nogueira, Roberta D'Ambrosio, Pietro Lampertico, Khalid M AlNaamani, A G Holleboom, Arun Valsan, Arathi Venu, Mohamed El-Kassas, Grazia Pennisi, Ying Shang, Wen-Yue Liu, Hye Won Lee, Takashi Kobayashi, Satoru Kakizaki, Cyrielle Caussy, Brian Pearlman, Paula Iruzubieta, Rida Nadeem, Felice Cinque, Antonia Neonaki, Mirko Zoncapé, Rui-Xu Yang, Sherlot Juan Song, Nicholas Dunn, Zouhir Gadi, Ming-Lun Yeh, Kevin Kim-Jun Teh, Sanjiv Mahadeva, Licet Gonzalez Fabian, Ahmed Almohsen, Nathalie Leite, Nicola Pugliese, Johan Vessby, Chencheng Xie, Narendra Singh Choudhary, Ethan Friend, Maria Poca, Takumi Kawaguchi, Francesco Paolo Russo, Adrian Gadano, Luis Antonio Diaz, Ashwani K Singal, Berenice Segrestin, Nadege Gunn, Didac Mauricio, Marco Arrese, Anna Fracanzani, Rosa Lombardi, Brian Lam, Andrei Racila, Saleh A Alqahtani, Maria Stepanova +86 moreopenaire +4 more sourcesGlobal performance of non-invasive tests in MASLD: Insights from the G-MASLD study
Hepatology Background: Metabolic dysfunction–associated steatotic liver disease (MASLD) is highly prevalent worldwide. Performance of non-invasive tests (NITs) in patients with MASLD recruited from different regions of the world was evaluated. Methods: Younossi, Zobair M., de Avila, Leyla, Petta, Salvatore, Hagström, Hannes, Kim, Seung Up, Nakajima, Atsushi, Crespo, Javier, Castera, Laurent, Alkhouri, Naim, Zheng, Ming-Hua, Treeprasertsuk, Sombat, Ananchuensook, Prooksa, Shalimar, null, Tsochatzis, Emmanuel, Trivikrama, Shenoy Kotacherry, Balakumaran, Leena Kondarappassery, Fan, Jian-Gao, Roberts, Stuart K., Alswat, Khalid, Wong, Vincent Wai-Sun, Yilmaz, Yusuf, Dunn, Winston, Francque, Sven, Cordie, Ahmed, Yu, Ming-Lung, Ekstedt, Mattias, Goh, George Boon-Bee, Oliveira, Claudia P., Pessoa, Mario Guimaraes, Chan, Wah Kheong, Fernandez, Marlen Ivon Castellanos, Duseja, Ajay, Arab, Juan Pablo, Papatheodoridis, George, Sebastiani, Giada, Villela-Nogueira, Cristiane, D'Ambrosio, Roberta, Lampertico, Pietro, Alnaamani, Khalid, Holleboom, A. G., Valsan, Arun, Venu, Arathi, El-Kassas, Mohamed, Pennisi, Grazia, Shang, Ying, Liu, Wen-Yue, Lee, Hye Won, Kobayashi, Takashi, Kakizaki, Satoru, Caussy, Cyrielle, Pearlman, Brian, Iruzubieta, Paula, Nadeem, Rida, Cinque, Felice, Neonaki, Antonia, Zoncapé, Mirko, Yang, Rui-Xu, Song, Sherlot Juan, Dunn, Nicholas, Gadi, Zouhir, Yeh, Ming-Lun, Kim-Jun, Kevin, Mahadeva, Sanjiv, Fabian, Licet Gonzalez, Almohsen, Ahmed, Leite, Nathalie, Pugliese, Nicola, Vessby, Johan, Xie, Chencheng, Choudhary, Narendra Singh, Friend, Ethan, Poca, Maria, Kawaguchi, Takumi, Russo, Francesco Paolo, Gadano, Adrian, Diaz, Luis Antonio, Singal, Ashwani K., Segrestin, Berenice, Gunn, Nadege, Mauricio, Didac, Arrese, Marco, Fracanzani, Anna, Lombardi, Rosa, Lam, Brian, Racila, Andrei, Alqahtani, Saleh A., Stepanova, Maria, null, null +87 moreopenaire +5 more sourcesMASLD as Complication of Diabetes
Diabetes Worldwide metabolic dysfunction–associated steatotic liver disease (MASLD) is the leading cause of chronic liver disease. Despite high global prevalence, MASLD is not yet recognized as a noncommunicable disease, although all of the criteria are fulfilled for such a classification.openaire +1 more sourceTranscriptome profiling in MASLD
Soavtorji iz Slovenije: Tadeja Režen, Miha Moškon, Damjana Rozman.Kočar, Eva, Giraudi, Pablo J, Palmisano, Silvia, Režen, Tadeja, Tiribelli, Claudio, Rosso, Natalia, Moškon, Miha, računalništvo, Rozman, Damjana +7 moreopenaire +1 more source
